Top Markets
Coin of the day
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Classement en actions #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Prix de l'action
$0.30840035
Capitalisation boursière
$94.37M
Changement (1 jour)
0.00%
Changement (1 an)
-34.60%
Pays
FR
Échange Sensorion SA (ALSEN)

Catégorie

Historique des divisions d’actions pour Sensorion SA (ALSEN)
L’action Sensorion SA (symbole : ALSEN) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Jul 13, 2026.
Une action ALSEN achetée avant le Jul 13, 2026 équivaudrait aujourd’hui à 0 actions ALSEN.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
5 x199
DK
1 x2
US
0 -
US
0 -
BE
0 -
NL